RCM
CVS icon

Riverhead Capital Management’s CVS Health CVS Stock Holding History

Riverhead Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$822K Sell
13,027
-2,061
-14% -$122K 0.03% 541
2019
Q2 		$822K Sell
15,088
-16,439
-52% -$885K 0.03% 553
2019
Q1 		$1.7M Sell
31,527
-26,752
-46% -$1.65M 0.07% 352
2018
Q4 		$3.82M Buy
58,279
+11,089
+23% +$828K 0.17% 162
2018
Q3 		$3.71M Sell
47,190
-17,349
-27% -$1.24M 0.13% 206
2018
Q2 		$4.15M Sell
64,539
-17,642
-21% -$1.16M 0.16% 177
2018
Q1 		$5.11M Sell
82,181
-51,517
-39% -$3.7M 0.22% 120
2017
Q4 		$9.69M Sell
133,698
-3,228
-2% -$235K 0.41% 50
2017
Q3 		$11.1M Buy
136,926
+39,135
+40% +$3.1M 0.52% 37
2017
Q2 		$7.87M Buy
97,791
+31,510
+48% +$2.49M 0.39% 51
2017
Q1 		$5.2M Buy
66,281
+19,255
+41% +$1.54M 0.29% 95
2016
Q4 		$3.71M Sell
47,026
-15,640
-25% -$1.27M 0.23% 127
2016
Q3 		$5.58M Buy
62,666
+59,333
+1,780% +$5.6M 0.36% 61
2016
Q2 		$167K Sell
3,333
-349,931
-99% -$34.9M 0.01% 970
2016
Q1 		$36.6M Sell
353,264
-96,804
-22% -$9.41M 0.52% 39
2015
Q4 		$44M Buy
450,068
+80,679
+22% +$7.9M 0.64% 24
2015
Q3 		$35.6M Sell
369,389
-151,807
-29% -$16M 0.56% 35
2015
Q2 		$54.7M Sell
521,196
-4,237
-0.8% -$433K 0.83% 17
2015
Q1 		$54.2M Sell
525,433
-118,115
-18% -$12M 0.82% 12
2014
Q4 		$62M Buy
643,548
+10,352
+2% +$912K 0.94% 9
2014
Q3 		$50.4M Buy
633,196
+143,955
+29% +$11.3M 0.87% 13
2014
Q2 		$36.9M Buy
489,241
+221,506
+83% +$16.7M 0.69% 31
2014
Q1 		$20M Buy
267,735
+149,247
+126% +$10.5M 0.44% 57
2013
Q4 		$8.48M Sell
118,488
-154,622
-57% -$9.93M 0.22% 134
2013
Q3 		$15.5M Buy
273,110
+116,000
+74% +$6.91M 0.5% 53
2013
Q2 		$8.98M Buy
+157,110
New +$9.1M 0.3% 93

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Riverhead Capital Management's CVS Position: Q3 2019 in Review

Riverhead Capital Management reduced its CVS Health (CVS) stake by 14% in Q3 2019, selling an estimated $122K and leaving 13,027 shares worth $822K. The position accounts for 0.03% of the portfolio, ranked #541.

Riverhead Capital Management first reported a position in CVS in Q2 2013 and has held it in 26 quarters since. The position peaked at $62M in Q4 2014. 1,684 funds tracked by Wall St. Rank hold CVS as of Q3 2019.

  • Riverhead Capital Management held 13,027 shares of CVS Health worth $822K as of Q3 2019.
  • Riverhead Capital Management sold 2,061 CVS Health shares in Q3 2019, an estimated $122K.
  • CVS Health made up 0.03% of Riverhead Capital Management's portfolio in Q3 2019, its #541 holding.
  • Riverhead Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 26 quarters since.
  • Riverhead Capital Management's CVS Health position peaked at $62M in Q4 2014.
  • 1,684 funds tracked by Wall St. Rank held CVS Health as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.